References
- Global Initiative for Asthma. Global strategy for asthma management and prevention. [accessed 2019 Aug 7]. Available from: http://www.ginasthma.org/.
- Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:https://doi.org/10.1183/09031936.00202013.
- Matsunaga K, Hamada K, Oishi K, Yano M, Yamaji Y, Hirano T. Factors associated with physician-patient discordance in the perception of asthma control. J Allergy Clin Immunol Pract. 2019;7(8):2634–2641. doi:https://doi.org/10.1016/j.jaip.2019.04.046.
- Juniper EF, Chauhan A, Neville E, Chatterjee A, Svensson K, Mörk A-C, Ståhl E. Clinicians tend to overestimate improvements in asthma control: an unexpected observation. Prim Care Respir J. 2004;13(4):181–184. doi:https://doi.org/10.1016/j.pcrj.2004.04.003.
- Urrutia I, Plaza V, Pascual S, Cisneros C, Entrenas LM, Luengo MT, Caballero F. Asthma control and concordance of opinions between patients and pulmonologists. J Asthma. 2013;50(8):877–883. doi:https://doi.org/10.3109/02770903.2013.819886.
- Menzies-Gow A, Chiu G. Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals’ perceptions of asthma control with validated ACT scores. NPJ Prim Care Respir Med. 2017;27(1):48. doi:https://doi.org/10.1038/s41533-017-0050-x.
- Royal College of Physicians. Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report. London: Royal College of Physicians; 2014.
- Ambrose CS, Chipps BE, Moore WC, Soong W, Trevor J, Ledford DK, Carr WW, Lugogo N, Trudo F, Tran TN, et al. The CHRONICLE study of US adults with subspecialist-treated severe asthma: objectives, design, and initial results. Pragmat Obs Res. 2020;11:77–90. doi:https://doi.org/10.2147/POR.S251120.
- Moore WC, Panettieri RA, Trevor J, Ledford DK, Lugogo N, Soong W, Chipps BE, Carr W, Belton L, Gandhi H, et al. Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma. Ann Allergy Asthma Immunol. 2020;125(3):294–303.e1. doi:https://doi.org/10.1016/j.anai.2020.04.004.
- Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:https://doi.org/10.1016/j.jaci.2003.09.008.
- Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549–556. doi:https://doi.org/10.1016/j.jaci.2006.01.011.
- Lloyd A, Turk F, Leighton T, Walter Canonica G. Psychometric evaluation of Global Evaluation of Treatment Effectiveness: a tool to assess patients with moderate-to-severe allergic asthma. J Med Econ. 2007;10(3):285–296. doi:https://doi.org/10.3111/13696990701478856.
- National Heart, Lung, and Blood Institute. National asthma education and prevention program. Expert panel report 3: guidelines for the diagnosis and management of asthma. Full report 2007. Bethesda, MD: NHLBI Health Information Center; 2007.
- Chipps BE, Corren J, Israel E, Katial R, Lang DM, Panettieri RA, Peters SP, Farrar JR. Asthma yardstick: practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma. Ann Allergy Asthma Immunol. 2017;118(2):133–142.e3. doi:https://doi.org/10.1016/j.anai.2016.12.010.
- Murphy KR, Chipps B, Beuther DA, Wise RA, McCann W, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Coyne KS, et al. Development of the Asthma Impairment and Risk Questionnaire (AIRQ): a composite control measure. J Allergy Clin Immunol Pract. 2020;8(7):2263–2274.e5. doi:https://doi.org/10.1016/j.jaip.2020.02.042.
- Kritikos V, Price D, Papi A, Infantino A, Ställberg B, Ryan D, Lavorini F, Chrystyn H, Haughney J, Lisspers K, et al. A multinational observational study identifying primary care patients at risk of overestimation of asthma control. NPJ Prim Care Respir Med. 2019;29(1):43. doi:https://doi.org/10.1038/s41533-019-0156-4.
- Crespo-Lessmann A, Plaza V, Gonzalez-Barcala FJ, Fernandez-Sanchez T, Sastre J. Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate-severe asthma. BMJ Open Respir Res. 2017;4(1):e000189. doi:https://doi.org/10.1136/bmjresp-2017-000189.
- Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16(5):802–807. doi:https://doi.org/10.1183/09031936.00.16580200.
- Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med. 2002;96(3):142–149. doi:https://doi.org/10.1053/rmed.2001.1241.
- Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009. doi:https://doi.org/10.1038/npjpcrm.2014.9.